SlideShare a Scribd company logo
CRISPR
Dr Navnika Kapoor
2nd Year MD Pharmacology student
VPCI, Delhi
1
CRISPR
• Clustered
• Regularly
• Interspaced
• Short
• Palindromic
• Repeat
2
3
To Discuss
• Gene therapy
• History of CRISPR
• Mechanism of CRISPR Cas 9 Technology
• Advantages of CRISPR
• Limitations of CRISPR
• Overcoming the Limitations
• Delivery of CRISPR gene therapy
• Application
• Summary 4
Gene Therapy
• Technique that modifies a person genes to treat a disease
5
Why shift from traditional gene therapy to CRISPR
1. Immunotoxicity
2. Oncogenesis
• Examples :
1. Clinical trial ( in US ) non-mutated OTC ( Ornithine trans Carbamoylase ) gene was
delivered to the liver hepatic artery injection of the recombinant adenoviral vector
housing the therapeutic gene Jessie a 18 yr old with a mild form of OTC deficiency
participated in the trial 4 days after the trial he died ( Immunotoxicity from the
adenovirus vector )
6
2. Gene therapy trial
Use of retroviral vectors
Ex vivo delivery of therapeutic transgenes to autologous s CD34+ hematopoietic stem cells
5 Patients developed therapy related leukemia
( Integration of therapeutic gene into LMO2 protooncogene )
7
Hallmarks in the development of CRISPR gene therapy
8
CRISPR
• Clustered
• Regularly
• Interspaced
• Short
• Palindromic
• Repeats
9
CRISPR mediated bacterial adaptive immunity
10
CRISPR mediated gene editing
11
Advantages of CRISPR/ Cas 9
• Easy
• High Accuracy
• Fast
12
Limitations of CRISPR
13
Limitations
of CRISPR
Off target
effects
(OTE)
Immunotoxi
city
DNA
damage
toxicity
14
Overcoming the limitations
15
Off target effects
• Off target effects : Unintended mutations at the site other than target
• Factors causing the off target effects :
1. Excess affinity between Cas 9 and the target DNA
2. Features in the sgRNA :
• Seed sequence : 10-12 bp region proximal to PAM ( Protospacer adjacent motif )
• GC content
3. Repair pathway involved ( NHEJ or HDR )
16
Overcoming the off target effects
• SpCas9HF-1 variant ( High fidelity )
Introduces mutation to 4 residues involved in direct hydrogen bonding between Cas 9 and the
Phosphate backbone of target DNA
Reduces the excess affinity between Cas 9 and target DNA
• Evo Cas 9 and HiFi Cas 9
Altered amino acid residues in the Rec 3 domain ( Nucleotide recognition )
Increases the specificity to induce double stranded Breaks ( DSB ) 17
Overcoming the off target effects cont.…
• Cas9_R63A/Q768A Variant
R 63 A mutation destabilizes the R Loop formation In the presence of Mismatches
Q 768 Mutation increases the sensitivity to PAM Distal mismatches
• Optimize Guide design platforms such as :
1. E-Crisp
2. CRISPR-design
3. CasOFFinder
18
Overcoming the DNA damage toxicity
• Crispr induced double stranded breaks :
1. Induce apoptosis rather than the desired gene edit ( p 53 Activation )
2. Large deletions and complex rearrangements
• Method of overcoming the DNA damage toxicity and off target effects is Precise genome
editing
19
Precise gene editing with CRISPR
20
Overcoming Immunotoxicity
1. Using of Non Viral vectors ( Nanoparticles, Exosomes, Liposomes )
2. New Cas 9 Variants with reduced Immunogenic risk like Cj Cas 9 ( Cas 9 from
Campylobacter Jejuni )
21
Delivery of CRISPR gene therapy
22
23
Advantages and Disadvantages of Ex Vivo Delivery
• Advantages :
1. Greater safety ( Patient not exposed to gene altering tool )
2. Technical feasibility
3. Tighter Quality control of the edited cells
• Disadvantages :
1. Survival and retention of in Vivo function of the cells outside the patient
2. Limitation of the method to certain cell type that can survive and be expanded in culture
(hematopoietic stem and progenitor cells (HSPCs) and T cells )
• This therapy provides benefits in Hematological disorder and Cancer immunotherapy24
Advantages and Disadvantages of In Vivo delivery
• Advantage :
• Expression of the gene editing toolkit can be controlled to target specific organs
• Disadvantage :
1. Degradation by circulating proteases or nucleases, opsonization by opsonin
2. Cargo must reach the target tissue and bypass the vascular endothelium (preventing
accessibility to larger delivery vehicles (>1 nm diameter).
25
Applications of CRISPR gene therapy
26
Disease Gene target CRISPR-Cas 9 mediated
intervention
Metastatic Non small cell lung
cancer
PDCD-1 CRISPR-Cas9 mediated PD-1
knockout-T cells
from autologous origin
Metastatic Renal Cell
Carcinoma
PDCD-1 CRISPR-Cas9 mediated PD-1
knockout-T cells from
autologous origin
Esophageal Cancer PDCD-1 CRISPR-Cas9 mediated PD-1
knockout-T cells from
autologous origin
27
Covid-19
• PAC-MAN (prophylactic antiviral CRISPR in human cells) is a CRISPR-Cas13-based strategy
as a Therapeutic application against COVID 19
• RNA guided RNA endonuclease activity of Cas13d in human cells to eliminate the SARS-CoV-
2 virus
• CRISPR based detection tools such as SHERLOCK, DETECTR, and FELUDA for COVID
19
28
Sickle cell anaemia
• Exagamglogene autotemcel ( Exa- cel ) by vertex pharmaceuticals for Sickle cell anaemia (
Stage III clinical trial )
29
Summary
• CRISPR is Clustered regular interspaced short palindromic repeats
• It is a bacterial adaptive immune response
• CRISPR locus consist of trRNA ( trans RNA ), Cas ( CRISPR associated endonuclease ), PAM
(Protospacer adjacent Motif ), Spacer ( incorporated viral fragment ) which further transcribe
into crRNA ( CRISPR RNA )
• trRNA and crRNA can be combined to form sgRNA ( single guide RNA ) guides Cas to
cause Cleavage at the desired site ( recognition by PAM )
• It is easy, fast and Highly accurate technology
• Limitations include Off target effects, Immunotoxicity, and DNA damage toxicity
30
• Off target effect can be reduced by certain Cas Variants such as SpCas9HF-1 variant, Evo Cas 9 and
HiFi Cas 9, Cas9_R63A/Q768A Variant
• Off target effects and DNA induced toxicity can also be reduced by Precise Gene editing
• Precise gene editing involves three methods : CRISPR/Cas 9 HDR ( Using ssODN ), Base editors (
Adenosine base editors and cytosine base editor ) and Prime editor ( Cas 9n and prime editor guide
RNA ( peg RNA ) )
• Delivery of CRISPR can be by Ex Vivo or In Vivo method
• Delivery agents include Physical method ( Electroporation, Microinjection ), Viral Vectors
(Adenovirus ) and Non viral vectors ( Nanoparticles )
• Applications Include in Cancer, COVID 19 ( Detection ( DETECTR ) and therapeutic ( PAC-MAN ) )
• Exagamglogene autotemcel ( Exa- cel ) for Sickle cell anaemia
31
References
• Uddin F, Rudin M, Sen T. CRISPR Gene Therapy: Applications, Limitations, and Implications
for the Future. Front. Oncol.2020;10:1387.
• Zhang XH, Tee LY, Wang XG, Huang QS, Yang SH. Off-target Effects in CRISPR/Cas9-
mediated Genome Engineering. Mol Ther Nucleic Acids. 2015 Nov 17;4(11):e264.
• Zhu Y. Advances in CRISPR/Cas9. Biomed Res Int. 2022;2022:9978571.
• Liu W, Li L, Jiang J, Wu M, Lin P. Applications and challenges of CRISPR-Cas gene-editing to
disease treatment in clinics. Precis Clin Med. 2021;4(3):179-191.
32
Thank You
33

More Related Content

Similar to CRISPR.pptx

Crispr cas9
Crispr cas9Crispr cas9
Translating Genomes | Personalizing Medicine
Translating Genomes | Personalizing MedicineTranslating Genomes | Personalizing Medicine
Translating Genomes | Personalizing Medicine
Candy Smellie
 
Genome Editing & Gene Therapy by Eric Kelsic
Genome Editing & Gene Therapy by Eric KelsicGenome Editing & Gene Therapy by Eric Kelsic
Genome Editing & Gene Therapy by Eric Kelsic
Impact.Tech
 
3.i
3.i3.i
CRISPR Cas 9 TECHNOLOGY
CRISPR Cas 9 TECHNOLOGYCRISPR Cas 9 TECHNOLOGY
CRISPR Cas 9 TECHNOLOGY
MadihaAsad5
 
PadminiNarayanan-Intro-2018.pptx
PadminiNarayanan-Intro-2018.pptxPadminiNarayanan-Intro-2018.pptx
PadminiNarayanan-Intro-2018.pptx
DESMONDEZIEKE1
 
Understanding and controlling for sample and platform biases in NGS assays
Understanding and controlling for sample and platform biases in NGS assaysUnderstanding and controlling for sample and platform biases in NGS assays
Understanding and controlling for sample and platform biases in NGS assays
Candy Smellie
 
Genome editing with engineered nucleases
Genome editing with engineered nucleasesGenome editing with engineered nucleases
Genome editing with engineered nucleases
Krishan Kumar
 
6. Molek tech.pptx [Repaired].pptx
6. Molek tech.pptx [Repaired].pptx6. Molek tech.pptx [Repaired].pptx
6. Molek tech.pptx [Repaired].pptx
ArdiansyahPrayitno2
 
CRISPR AND ITS APPLICATION in modern era
CRISPR AND ITS APPLICATION in modern eraCRISPR AND ITS APPLICATION in modern era
CRISPR AND ITS APPLICATION in modern era
Dr. Nagendra Kumar
 
CRISPR in crop Improvement, CRISPR/Cas Genome editing tool
CRISPR in crop Improvement, CRISPR/Cas Genome editing toolCRISPR in crop Improvement, CRISPR/Cas Genome editing tool
CRISPR in crop Improvement, CRISPR/Cas Genome editing tool
ParthasarathiG2
 
Crispr cas9 scalpels and their application
Crispr cas9 scalpels and their applicationCrispr cas9 scalpels and their application
Crispr cas9 scalpels and their application
Pyarelal Syoran
 
Gene rx [autosaved]
Gene rx [autosaved]Gene rx [autosaved]
Gene rx [autosaved]
chandiniyrao
 
Newer drug delivery systems
Newer drug delivery systemsNewer drug delivery systems
Newer drug delivery systems
chandiniyrao
 
CRISPR-Cas9 system a tool for gene editing presentation
CRISPR-Cas9 system a tool for gene editing presentation CRISPR-Cas9 system a tool for gene editing presentation
CRISPR-Cas9 system a tool for gene editing presentation
RashmiSharma304
 
Chronic granulomatous disease
Chronic granulomatous diseaseChronic granulomatous disease
CRISPR, cas9 in plant disease resistance
CRISPR, cas9 in plant disease resistance CRISPR, cas9 in plant disease resistance
CRISPR, cas9 in plant disease resistance
N.H. Shankar Reddy
 
Poster
PosterPoster
Poster
Casey Patch
 
CRISPR LECTURE.pptx
CRISPR LECTURE.pptxCRISPR LECTURE.pptx
CRISPR LECTURE.pptx
SamayaKhan3
 
YASHIKA JAISWAL 1 (3) (1).pptx
YASHIKA JAISWAL 1 (3) (1).pptxYASHIKA JAISWAL 1 (3) (1).pptx
YASHIKA JAISWAL 1 (3) (1).pptx
YashikaJaiswal10
 

Similar to CRISPR.pptx (20)

Crispr cas9
Crispr cas9Crispr cas9
Crispr cas9
 
Translating Genomes | Personalizing Medicine
Translating Genomes | Personalizing MedicineTranslating Genomes | Personalizing Medicine
Translating Genomes | Personalizing Medicine
 
Genome Editing & Gene Therapy by Eric Kelsic
Genome Editing & Gene Therapy by Eric KelsicGenome Editing & Gene Therapy by Eric Kelsic
Genome Editing & Gene Therapy by Eric Kelsic
 
3.i
3.i3.i
3.i
 
CRISPR Cas 9 TECHNOLOGY
CRISPR Cas 9 TECHNOLOGYCRISPR Cas 9 TECHNOLOGY
CRISPR Cas 9 TECHNOLOGY
 
PadminiNarayanan-Intro-2018.pptx
PadminiNarayanan-Intro-2018.pptxPadminiNarayanan-Intro-2018.pptx
PadminiNarayanan-Intro-2018.pptx
 
Understanding and controlling for sample and platform biases in NGS assays
Understanding and controlling for sample and platform biases in NGS assaysUnderstanding and controlling for sample and platform biases in NGS assays
Understanding and controlling for sample and platform biases in NGS assays
 
Genome editing with engineered nucleases
Genome editing with engineered nucleasesGenome editing with engineered nucleases
Genome editing with engineered nucleases
 
6. Molek tech.pptx [Repaired].pptx
6. Molek tech.pptx [Repaired].pptx6. Molek tech.pptx [Repaired].pptx
6. Molek tech.pptx [Repaired].pptx
 
CRISPR AND ITS APPLICATION in modern era
CRISPR AND ITS APPLICATION in modern eraCRISPR AND ITS APPLICATION in modern era
CRISPR AND ITS APPLICATION in modern era
 
CRISPR in crop Improvement, CRISPR/Cas Genome editing tool
CRISPR in crop Improvement, CRISPR/Cas Genome editing toolCRISPR in crop Improvement, CRISPR/Cas Genome editing tool
CRISPR in crop Improvement, CRISPR/Cas Genome editing tool
 
Crispr cas9 scalpels and their application
Crispr cas9 scalpels and their applicationCrispr cas9 scalpels and their application
Crispr cas9 scalpels and their application
 
Gene rx [autosaved]
Gene rx [autosaved]Gene rx [autosaved]
Gene rx [autosaved]
 
Newer drug delivery systems
Newer drug delivery systemsNewer drug delivery systems
Newer drug delivery systems
 
CRISPR-Cas9 system a tool for gene editing presentation
CRISPR-Cas9 system a tool for gene editing presentation CRISPR-Cas9 system a tool for gene editing presentation
CRISPR-Cas9 system a tool for gene editing presentation
 
Chronic granulomatous disease
Chronic granulomatous diseaseChronic granulomatous disease
Chronic granulomatous disease
 
CRISPR, cas9 in plant disease resistance
CRISPR, cas9 in plant disease resistance CRISPR, cas9 in plant disease resistance
CRISPR, cas9 in plant disease resistance
 
Poster
PosterPoster
Poster
 
CRISPR LECTURE.pptx
CRISPR LECTURE.pptxCRISPR LECTURE.pptx
CRISPR LECTURE.pptx
 
YASHIKA JAISWAL 1 (3) (1).pptx
YASHIKA JAISWAL 1 (3) (1).pptxYASHIKA JAISWAL 1 (3) (1).pptx
YASHIKA JAISWAL 1 (3) (1).pptx
 

Recently uploaded

A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
Dr. Jyothirmai Paindla
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
MedicoseAcademics
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Ayurveda ForAll
 
The Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in IndiaThe Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in India
Swastik Ayurveda
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
rishi2789
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Swastik Ayurveda
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
suvadeepdas911
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
LaniyaNasrink
 
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
rightmanforbloodline
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
chiranthgowda16
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
Jim Jacob Roy
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
BrissaOrtiz3
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
walterHu5
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
suvadeepdas911
 
Ketone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistryKetone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistry
Dhayanithi C
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
Dr. Jyothirmai Paindla
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Health Advances
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
Dr. Jyothirmai Paindla
 

Recently uploaded (20)

A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
 
The Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in IndiaThe Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in India
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
 
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
 
Ketone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistryKetone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistry
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
 

CRISPR.pptx

  • 1. CRISPR Dr Navnika Kapoor 2nd Year MD Pharmacology student VPCI, Delhi 1
  • 2. CRISPR • Clustered • Regularly • Interspaced • Short • Palindromic • Repeat 2
  • 3. 3
  • 4. To Discuss • Gene therapy • History of CRISPR • Mechanism of CRISPR Cas 9 Technology • Advantages of CRISPR • Limitations of CRISPR • Overcoming the Limitations • Delivery of CRISPR gene therapy • Application • Summary 4
  • 5. Gene Therapy • Technique that modifies a person genes to treat a disease 5
  • 6. Why shift from traditional gene therapy to CRISPR 1. Immunotoxicity 2. Oncogenesis • Examples : 1. Clinical trial ( in US ) non-mutated OTC ( Ornithine trans Carbamoylase ) gene was delivered to the liver hepatic artery injection of the recombinant adenoviral vector housing the therapeutic gene Jessie a 18 yr old with a mild form of OTC deficiency participated in the trial 4 days after the trial he died ( Immunotoxicity from the adenovirus vector ) 6
  • 7. 2. Gene therapy trial Use of retroviral vectors Ex vivo delivery of therapeutic transgenes to autologous s CD34+ hematopoietic stem cells 5 Patients developed therapy related leukemia ( Integration of therapeutic gene into LMO2 protooncogene ) 7
  • 8. Hallmarks in the development of CRISPR gene therapy 8
  • 9. CRISPR • Clustered • Regularly • Interspaced • Short • Palindromic • Repeats 9
  • 10. CRISPR mediated bacterial adaptive immunity 10
  • 11. CRISPR mediated gene editing 11
  • 12. Advantages of CRISPR/ Cas 9 • Easy • High Accuracy • Fast 12
  • 16. Off target effects • Off target effects : Unintended mutations at the site other than target • Factors causing the off target effects : 1. Excess affinity between Cas 9 and the target DNA 2. Features in the sgRNA : • Seed sequence : 10-12 bp region proximal to PAM ( Protospacer adjacent motif ) • GC content 3. Repair pathway involved ( NHEJ or HDR ) 16
  • 17. Overcoming the off target effects • SpCas9HF-1 variant ( High fidelity ) Introduces mutation to 4 residues involved in direct hydrogen bonding between Cas 9 and the Phosphate backbone of target DNA Reduces the excess affinity between Cas 9 and target DNA • Evo Cas 9 and HiFi Cas 9 Altered amino acid residues in the Rec 3 domain ( Nucleotide recognition ) Increases the specificity to induce double stranded Breaks ( DSB ) 17
  • 18. Overcoming the off target effects cont.… • Cas9_R63A/Q768A Variant R 63 A mutation destabilizes the R Loop formation In the presence of Mismatches Q 768 Mutation increases the sensitivity to PAM Distal mismatches • Optimize Guide design platforms such as : 1. E-Crisp 2. CRISPR-design 3. CasOFFinder 18
  • 19. Overcoming the DNA damage toxicity • Crispr induced double stranded breaks : 1. Induce apoptosis rather than the desired gene edit ( p 53 Activation ) 2. Large deletions and complex rearrangements • Method of overcoming the DNA damage toxicity and off target effects is Precise genome editing 19
  • 20. Precise gene editing with CRISPR 20
  • 21. Overcoming Immunotoxicity 1. Using of Non Viral vectors ( Nanoparticles, Exosomes, Liposomes ) 2. New Cas 9 Variants with reduced Immunogenic risk like Cj Cas 9 ( Cas 9 from Campylobacter Jejuni ) 21
  • 22. Delivery of CRISPR gene therapy 22
  • 23. 23
  • 24. Advantages and Disadvantages of Ex Vivo Delivery • Advantages : 1. Greater safety ( Patient not exposed to gene altering tool ) 2. Technical feasibility 3. Tighter Quality control of the edited cells • Disadvantages : 1. Survival and retention of in Vivo function of the cells outside the patient 2. Limitation of the method to certain cell type that can survive and be expanded in culture (hematopoietic stem and progenitor cells (HSPCs) and T cells ) • This therapy provides benefits in Hematological disorder and Cancer immunotherapy24
  • 25. Advantages and Disadvantages of In Vivo delivery • Advantage : • Expression of the gene editing toolkit can be controlled to target specific organs • Disadvantage : 1. Degradation by circulating proteases or nucleases, opsonization by opsonin 2. Cargo must reach the target tissue and bypass the vascular endothelium (preventing accessibility to larger delivery vehicles (>1 nm diameter). 25
  • 26. Applications of CRISPR gene therapy 26
  • 27. Disease Gene target CRISPR-Cas 9 mediated intervention Metastatic Non small cell lung cancer PDCD-1 CRISPR-Cas9 mediated PD-1 knockout-T cells from autologous origin Metastatic Renal Cell Carcinoma PDCD-1 CRISPR-Cas9 mediated PD-1 knockout-T cells from autologous origin Esophageal Cancer PDCD-1 CRISPR-Cas9 mediated PD-1 knockout-T cells from autologous origin 27
  • 28. Covid-19 • PAC-MAN (prophylactic antiviral CRISPR in human cells) is a CRISPR-Cas13-based strategy as a Therapeutic application against COVID 19 • RNA guided RNA endonuclease activity of Cas13d in human cells to eliminate the SARS-CoV- 2 virus • CRISPR based detection tools such as SHERLOCK, DETECTR, and FELUDA for COVID 19 28
  • 29. Sickle cell anaemia • Exagamglogene autotemcel ( Exa- cel ) by vertex pharmaceuticals for Sickle cell anaemia ( Stage III clinical trial ) 29
  • 30. Summary • CRISPR is Clustered regular interspaced short palindromic repeats • It is a bacterial adaptive immune response • CRISPR locus consist of trRNA ( trans RNA ), Cas ( CRISPR associated endonuclease ), PAM (Protospacer adjacent Motif ), Spacer ( incorporated viral fragment ) which further transcribe into crRNA ( CRISPR RNA ) • trRNA and crRNA can be combined to form sgRNA ( single guide RNA ) guides Cas to cause Cleavage at the desired site ( recognition by PAM ) • It is easy, fast and Highly accurate technology • Limitations include Off target effects, Immunotoxicity, and DNA damage toxicity 30
  • 31. • Off target effect can be reduced by certain Cas Variants such as SpCas9HF-1 variant, Evo Cas 9 and HiFi Cas 9, Cas9_R63A/Q768A Variant • Off target effects and DNA induced toxicity can also be reduced by Precise Gene editing • Precise gene editing involves three methods : CRISPR/Cas 9 HDR ( Using ssODN ), Base editors ( Adenosine base editors and cytosine base editor ) and Prime editor ( Cas 9n and prime editor guide RNA ( peg RNA ) ) • Delivery of CRISPR can be by Ex Vivo or In Vivo method • Delivery agents include Physical method ( Electroporation, Microinjection ), Viral Vectors (Adenovirus ) and Non viral vectors ( Nanoparticles ) • Applications Include in Cancer, COVID 19 ( Detection ( DETECTR ) and therapeutic ( PAC-MAN ) ) • Exagamglogene autotemcel ( Exa- cel ) for Sickle cell anaemia 31
  • 32. References • Uddin F, Rudin M, Sen T. CRISPR Gene Therapy: Applications, Limitations, and Implications for the Future. Front. Oncol.2020;10:1387. • Zhang XH, Tee LY, Wang XG, Huang QS, Yang SH. Off-target Effects in CRISPR/Cas9- mediated Genome Engineering. Mol Ther Nucleic Acids. 2015 Nov 17;4(11):e264. • Zhu Y. Advances in CRISPR/Cas9. Biomed Res Int. 2022;2022:9978571. • Liu W, Li L, Jiang J, Wu M, Lin P. Applications and challenges of CRISPR-Cas gene-editing to disease treatment in clinics. Precis Clin Med. 2021;4(3):179-191. 32

Editor's Notes

  1. CRISPR term was first coined in 2002 by Rudd Jansen, CRISPR locus was first described in 1993 by Fransisco Mojica